Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transdermally administered dextromethorphan as antitussive agent

Transdermally administered dextromethorphan as antitussive agent

US Patent 6335030 · Granted Jan 1, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Microrna-based method for assessing the prognosis of a prostate cancer patient2019
Transdermally administered tolterodine as anti-muscarinic agent for the treatmen2006
Transdermally administered tolterodine as anti-muscarinic agent for the treatmen2006
Therapeutic formulation for administering tolterodine with controlled release2004
Therapeutic formulation for administering tolterodine with controlled release2004
Transdermally administered acetylcysteine as mucolytic agent2003
Transdermally administered tolterodine as anti-muscarinic agent for the treatmen2003
Transdermally administered tolterodine as anti-muscarinic agent for the treatmen2003